A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca
✍ Scribed by Dianne Petrone; John J. Condemi; Rose Fife; Oscar Gluck; Stanley Cohen; Paul Dalgin
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 305 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0004-3591
- DOI
- 10.1002/art.510
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). ## Methods This pilot study was a 12‐week randomized, double‐blind, placebo‐controlled trial of etanercept, with 14 subjects in each group. Patients received 25 mg of e
A prospective, randomized, multicentre, double-blind placebo controlled study is described which compares the ecacy and tolerability of hypericum administered as a concentrated ethanolic extract of St John's wort (ZE117) to patients with mild±moderate depression (ICD-10; F 32 . 0 mild; F 32 . 1 mode